PatientsVille.com Logo

Neuralgia and Neuragen

PatientsVille

Neuralgia Symptoms and Causes

Shingles is a disease caused by the varicella-zoster virus - the same virus that causes chickenpox. After you have chickenpox, the virus stays in your body. It may not cause problems for many years. As you get older, the virus may reappear as shingles. Although it is most common in people over age 50, anyone who has had chickenpox is at risk.

You can't catch shingles from someone who has it. However, if you have a shingles rash, you can pass the virus to someone who has never had chickenpox. This would usually be a child, who could get chickenpox instead of shingles. The virus spreads through direct contact with the rash, and cannot spread through the air.

Early signs of shingles include burning or shooting pain and tingling or itching, usually on one side of the body or face. The pain can be mild to severe. Rashes or blisters appear anywhere from one to 14 days later. If shingles appears on your face, it may affect your vision or hearing. The pain of shingles may last for weeks, months, or even years after the blisters have healed.

There is no cure for shingles. Early treatment with medicines that fight the virus may help. These medicines may also help prevent lingering pain.

A vaccine may prevent shingles or lessen its effects. The vaccine is recommended for people 60 or over. In some cases doctors may give it to people ages 50 to 59.

NIH: National Institute of Allergy and Infectious Diseases

Check out the latest treatments for neuralgia

neuralgia treatment research studies

Neuragen clinical trials, surveys and public health registries


Find Drug Side Effect reports



Neuragen Side Effects

Swelling (5)
Blister (4)
Gait Disturbance (2)
Erythema (1)
Chemical Injury (1)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

<b>Describe Your Bisoprolol Experience Here:&lt;/b Trigeminal neuralgia. , left neurological chest pain Dose 1.25 twice daily</b>

Gleevec aggravating trigeminal neuralgia

Hi I take Oxcarbazepine for trigeminal neuralgia and i am having difficulty concentrating and seeing clearly, does anyone else have the same or similar experience

Hi Joe - if you already have heart failure, DO NOT take Lyrica. Warnings are on the leaflet within the tablet package. My husband increased his dosage (ignoring my warnings) to 750mg/day for severe trigeminal neuralgia, way above the recommended maxi

I am a homeopath.I am treating a patient, who is suffering from trigeminal neuralgia since 2 yrs.Previously he was a victim of repeated attacks of colds &amp; cough, &amp; he was using Actifed oral, half tablet twice/week,for 20 yrs.RCC stopp

I have an AVM. I was born with this, and it was first found in an MRI 13 years ago. While testing for my symptoms of facial pain (Neuralgia They didnt know it at the time) 2-1/2 years ago, I had another MRI. These results were compared to t

I was prescribed Lyrica by my doctor right after my 18th birthday. I was diagnosed with Post Herpetic Neuralgia (after pain from Shingles) when I was seventeen. Lyrica was the most horrible thing I've ever taken. While taking Lyrica, I was taking 18

James, I realised yours is an old posting, but 3 x 300mg a day is WAY over the maximum recommended dosage! My husband has trigeminal neuralgia and was so desperate to relieve the pain he put himself on 750mg a day (maximum is 600mg). As a direct resu

My husband died in Dec 2007 due to a contradiction of taking Lyrica with Effexor XR. He was taking Lyrica for post herpetic neuralgia. His doc decided in Noc '07 to have him take it daily (ie prophlactically), 2 weeks before his death the doc ha

Trigeminal neuralgia and Chantix. hs anyone been diagonoised with since stopping Chantix.

Neuralgia Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Not yet recruiting Osteoarthritis Structural Changes Assessed by Magnetic Resonance Imaging (MRI) and Neuropathic Pain in Knee Osteoarthritis
Conditions: Neuropathic Pain;   Knee Osteoarthritis
Intervention: Other: MRI
Outcome Measures: To correlate the level of neuropathic pain with the severity of OA structural changes (cartilage volume and defects, bone marrow lesions, meniscal tears and extrusion, synovitis).;   To assess the correlation between the presence of neuropathic pain and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores (total, pain, function, stiffness).
2 Unknown  Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain
Conditions: Postherpetic Neuralgia;   Neuralgia
Interventions: Drug: Etoricoxib;   Drug: Placebo
Outcome Measures: Time to Efficacy Failure;   To evaluate the efficacy of etoricoxib in NP during the Open-Label and the Double-Blind Periods;   Time to efficacy failure by PHN sub-group based on sensory testing results;   Safety as assessed by adverse events, serious adverse events, and vital signs
3 Not yet recruiting Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain
Conditions: Neuropathic Pain;   Spinal Cord Injuries
Interventions: Drug: Pregabalin;   Drug: Placebo
Outcome Measures: Daily at-level non-evoked pain intensity measured with the numerical rating scale (0-10) expressed as the mean 7-day pain intensity;   Weekly below-level non-evoked pain intensity measured with the numerical rating scale (0-10);   Weekly evaluation of at-level neuropathic pain symptoms using the "Neuropathic Pain Symptoms Inventory" (NPSI);   Weekly evaluation of at-level neuropathic pain intensity and interference using the "Brief Pain Inventory" (BPI);   Weekly evaluation of the change in at-level non-evoked neuropathic pain using the "Patient Global Impression Change" (PGIC);   Weekly evaluation of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS);   Weekly evaluation of spasm frequency below the spinal cord injury using the Penn questionnaire;   Measurement of the amplitude of cold and heat sensory evoked potentials (Cz-Fz) studied above (C4) and at-level of the SCI;   Serum TNF-R1 level;   Weekly at-level non-evoked pain intensity measured with the numerical rating scale (0-10) 28 days after the termination of the clinical trial;   Number of Paracetamol tablets used as rescue medication during the week;   Prevalence and type of adverse events in patients treated with pregabalin;   Unblinding testing: patient and investigator will be asked for the treatment they think to have received. Reasons for their judgement (efficacy and safety) will also be asked.
4 Recruiting Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve
Condition: Postherpetic Neuralgia
Interventions: Drug: Civamide Nasal Spray;   Drug: Placebo
Outcome Measure: Average Daily Pain Score
5 Recruiting Pulsed Radiofrequency vs. Steroid Injections for Occipital Neuralgia
Condition: Occipital Neuralgia
Interventions: Procedure: Pulsed radiofrequency;   Drug: Corticosteroid injection
Outcome Measures: Average pain score;   Number of headache days with severe headache;   Depression;   Disability;   Number of days with severe headache
6 Unknown  Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain
Conditions: Healthy Volunteers;   Patients Suffering of Peripheral Neuropathic Pain
Intervention: Other: Neuropathic pain
Outcome Measure: Comparison of the amplitude of N2P2 waves between healthy volunteers and patients suffering of peripheral neuropathic pain.
7 Not yet recruiting Early Administration of Botox® in Neuropathic Pain Due to Thoracoscopy or Thoracotomy
Conditions: Pain Due to Certain Specified Procedures;   Neuralgia
Interventions: Drug: BOTOX;   Other: PLACEBO
Outcome Measures: decrease in average pain intensity as measured by the Brief Pain Inventory (BPI);   VAS in the last 24 hours;   Neuropathic Pain Inventory
8 Recruiting A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety
Conditions: Neuropathic Pain;   Painful Diabetic Peripheral Neuropathy (PDPN);   Post-Herpetic Neuralgia (PHN)
Interventions: Drug: ASP8477;   Drug: Placebo
Outcome Measures: Change in mean of 24-hour average pain intensity, Numeric pain rating scale (NPRS);   Time to treatment failure;   Responder rate to ASP8477 in the Single-Blind Period;   Patient Global Impression of Change (PGIC) score;   Safety assessed by TEAE and SAE, laboratory tests, vital signs, C-SSRS, PWC and MWC scores, Bond-Lader score;   Composite of pharmacokinetics of ASP8477 concentration: Trough concentration (Ctrough), observed maximum concentration (Cmax), Area under the curve (AUC)0-6
9 Recruiting Acupuncture in Herpes Zoster Neuralgia (ACUZoster)
Conditions: Herpes Zoster;   Postherpetic Neuralgia;   Pain
Interventions: Device: Sham-laser acupuncture;   Drug: gabapentine;   Procedure: Acupuncture
Outcome Measures: Alteration of pain intensity after treatment;   Quantitative sensory testing
10 Unknown  Development of a Bedside Pain Assessment Kit for Postherpetic Neuralgia
Conditions: Neuralgia;   Herpes Zoster
Intervention:
Outcome Measure: Demonstrate usability of the BSTK.
11 Unknown  A Study of Patient Reported Outcomes After Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
Condition: Trigeminal Neuralgia
Intervention:
Outcome Measure: Patient satisfaction following CyberKnife radiosurgery
12 Unknown  Intravenous Immunoglobulin (IVIG) for Resistant Neuropathic Pain
Condition: Neuropathic Pain
Interventions: Biological: Intravenous immunoglobulin;   Biological: Normal Saline
Outcome Measures: The primary outcome measure will consist of change in mean daily pain diary score from baseline to each week post-treatment;   Measurement of neuroinflammation (NI) markers (IL-1β, IL-6, IL-8, TNF-α, MMP-9, TIMP-1)
13 Unknown  Effect of Opioids in Neuropathic Pain in Postherpetic Patients
Condition: Neuralgia, Postherpetic
Intervention: Drug: Remifentanil
Outcome Measures: Stimulus-response (SR)-function;   Pinprick;   Area of dynamic allodynia;   NRS;   Mechanical pain threshold;   HPPT;   HPTT;   Coolness;   Warmth;   LDPI
14 Unknown  Immunolabeling Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy Controls
Conditions: Postherpetic Neuralgia;   Healthy Age/Gender Matched Volunteers
Intervention: Other: skin biopsy
Outcome Measure: use of genetic data to enhance the search for targeted therapeutic approaches to chronic pain management
15 Unknown  To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients With Neuralgia of Various Origins
Condition: Neuralgia
Intervention: Drug: Dexamethasone
Outcome Measures: Observation of adverse events related to medication. The causality of adverse events concerning the use of medication will be given after applying the Naranjo Algorythm;   Efficacy evaluation Likert scale and Visual Analogue
16 Recruiting Virtual Walking for Neuropathic Pain in Spinal Cord Injury
Conditions: Spinal Cord Injury;   Neuropathic Pain
Interventions: Behavioral: Virtual walking;   Behavioral: Wheeling tape
Outcome Measures: Changes in Numeric Rating Scale;   Changes in fMRI correlates of neuropathic pain;   Changes in Pain Interference;   Changes in Neuropathic Pain Scale
17 Recruiting A Nasal Applicator for the Treatment of Trigeminal Neuralgia
Condition: Trigeminal Neuralgia
Intervention: Device: Nasal ganglion block for TN
Outcome Measures: Pain intensity numeric rating scale;   Patient's global impression of change
18 Recruiting A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia
Condition: Trigeminal Neuralgia
Interventions: Drug: Amifostine;   Procedure: CyberKnife stereotactic radiosurgery
Outcome Measures: Facial numbness following radiosurgery;   Pain relief following radiosurgery
19 Recruiting Botulinum Toxin for the Treatment of Trigeminal Neuralgia
Condition: Trigeminal Neuralgia
Intervention: Biological: Incobotulinumtoxina
Outcome Measures: Difference in mean number of attacks between active and placebo groups;   Difference in mean intensity between placebo and control groups
20 Recruiting Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
Condition: Trigeminal Neuralgia
Intervention:
Outcome Measure: DTI MRI findings